These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 9521303

  • 1. Albendazole therapy for neurocysticercosis.
    Takayanagui OM.
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521303
    [No Abstract] [Full Text] [Related]

  • 2. Albendazole therapy for neurocysticercosis.
    Ko DY, Chang GY.
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521302
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis.
    Garg RK, Kar AM, Jain S.
    J Assoc Physicians India; 1995 Oct; 43(10):706-7. PubMed ID: 8773009
    [No Abstract] [Full Text] [Related]

  • 6. Albendazole in neurocysticercosis.
    Padma MV, Behari M, Misra NK, Ahuja GK.
    Natl Med J India; 1995 Oct; 8(6):255-8. PubMed ID: 8520442
    [Abstract] [Full Text] [Related]

  • 7. Cerebral and subcutaneous cysticercosis treated with albendazole.
    Schmidt DK, Jordaan HF, Schneider JW, Cilliers J.
    Int J Dermatol; 1995 Aug; 34(8):574-9. PubMed ID: 7591443
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.
    Garcia HH, Gilman RH, Horton J, Martinez M, Herrera G, Altamirano J, Cuba JM, Rios-Saavedra N, Verastegui M, Boero J, Gonzalez AE.
    Neurology; 1997 May; 48(5):1421-7. PubMed ID: 9153484
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neurocysticercosis: treatment with albendazole.
    Horton J.
    Trans R Soc Trop Med Hyg; 1990 May; 84(1):174. PubMed ID: 2345923
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Albendazole therapy for neurocysticercosis.
    Escobedo F, Penagos P, Rodriguez J, Sotelo J.
    Arch Intern Med; 1987 Apr; 147(4):738-41. PubMed ID: 3827462
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone.
    Takayanagui OM, Lanchote VL, Marques MP, Bonato PS.
    Ther Drug Monit; 1997 Feb; 19(1):51-5. PubMed ID: 9029747
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J, Jung H.
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.